Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Alzheimer'S Disease: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Associated Genes | SNCA, GJA1, MDK, PTN, NTN1, SMOC1, GPNMB, NPTX2 |
| Therapeutic Agents | CI-994, Β-Sitosterol, Aducanumab, Cholinesterase Inhibitors, Memantine, Bispecific Antibodies |
| SciDEX Hypotheses | 70 hypotheses |
| KG Connections | 1546 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
Alzheimer_S_Disease["Alzheimer'S Disease"] -->|"involved in"| Pathogenic_Mechanisms["Pathogenic Mechanisms"]
style Pathogenic_Mechanisms fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
Alzheimer_S_Disease["Alzheimer'S Disease"] -->|"causes"| Cognitive_Decline["Cognitive Decline"]
style Cognitive_Decline fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
Alzheimer_S_Disease["Alzheimer'S Disease"] -->|"associated"| Sleep_Disruption["Sleep Disruption"]
style Sleep_Disruption fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
Alzheimer_S_Disease["Alzheimer'S Disease"] -->|"associated"| Genetics["Genetics"]
style Genetics fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
Alzheimer_S_Disease["Alzheimer'S Disease"] -->|"causes"| Memory_Deficits["Memory Deficits"]
style Memory_Deficits fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
Alzheimer_S_Disease["Alzheimer'S Disease"] -->|"causes"| Learning_Deficits["Learning Deficits"]
style Learning_Deficits fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
Alzheimer_S_Disease["Alzheimer'S Disease"] -->|"causes"| Cognitive_Impairment["Cognitive Impairment"]
style Cognitive_Impairment fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
GJA1["GJA1"] -->|"associated"| Alzheimer_S_Disease["Alzheimer'S Disease"]
style GJA1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
Amyloid_Beta["Amyloid-Beta"] -->|"contributes to"| Alzheimer_S_Disease["Alzheimer'S Disease"]
style Amyloid_Beta fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
Tau["Tau"] -->|"contributes to"| Alzheimer_S_Disease["Alzheimer'S Disease"]
style Tau fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
Bispecific_Antibodies["Bispecific Antibodies"] -->|"treats"| Alzheimer_S_Disease["Alzheimer'S Disease"]
style Bispecific_Antibodies fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
Amyloid_Beta_1["Amyloid Beta"] -->|"causes"| Alzheimer_S_Disease["Alzheimer'S Disease"]
style Amyloid_Beta_1 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
style Alzheimer_S_Disease fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Pathogenic Mechanisms | involved_in | mechanism | 0.95 |
| Cognitive Decline | causes | phenotype | 0.95 |
| Neurodegeneration | causes | process | 0.95 |
| Neuroinflammation | associated_with | process | 0.95 |
| TAU | associated_with | protein | 0.95 |
| Dementia | causes | disease | 0.95 |
| Neurodegeneration | associated_with | process | 0.95 |
| Gene Mutations | associated_with | mechanism | 0.95 |
| Amyloid Beta | associated_with | protein | 0.95 |
| Dementia | associated_with | disease | 0.95 |
| Long-Term Potentiation | associated_with | process | 0.95 |
| Tau Tangles | associated_with | biomarker | 0.95 |
| Microglia | associated_with | cell_type | 0.95 |
| Neuronal Loss | causes | phenotype | 0.95 |
| Amyloid-Beta Aggregation | involved_in | process | 0.95 |
| Cellular Senescence | associated_with | process | 0.95 |
| Sleep Disruption | associated_with | phenotype | 0.90 |
| Genetics | associated_with | process | 0.90 |
| Astrocyte Imbalance | associated_with | phenotype | 0.90 |
| Viral Vector Gene Therapy | treats | drug | 0.90 |
| Brain Structure | causes | phenotype | 0.90 |
| Cognition | causes | phenotype | 0.90 |
| Neuronal Death | causes | phenotype | 0.90 |
| Apoptosis | associated_with | process | 0.90 |
| Sleep Disturbance | causes | phenotype | 0.90 |
| Related Dementias | associated_with | disease | 0.90 |
| Blood-Brain Barrier | causes | process | 0.90 |
| Parvalbumin-Containing Interneurons | downregulates | cell_type | 0.90 |
| Nrg1-Erbb4 Signaling | associated_with | pathway | 0.90 |
| Disease-Associated Microglia | associated_with | cell_type | 0.90 |
| Proteinopathies | associated_with | mechanism | 0.90 |
| Pathology Accumulation | associated_with | process | 0.90 |
| Brain Blood Flow Regulation | associated_with | process | 0.90 |
| Synaptic Dysfunction | causes | process | 0.90 |
| anxiety | associated_with | disease | 0.90 |
| Memory Deficits | causes | phenotype | 0.85 |
| Learning Deficits | causes | phenotype | 0.85 |
| Cognitive Impairment | causes | phenotype | 0.85 |
| MICROGLIA | activates | cell_type | 0.85 |
| Neurocognitive Disorders | associated_with | disease | 0.85 |
| Atherosclerosis | associated_with | disease | 0.85 |
| Synaptic Transmission | associated_with | process | 0.85 |
| Disease-Associated Microglia | causes | phenotype | 0.85 |
| Microglial Heterogeneity | modulates | phenotype | 0.85 |
| Neurons | targets | cell_type | 0.85 |
| Middle Temporal Gyrus | associated_with | brain_region | 0.85 |
| Heterogeneous Molecular Changes | associated_with | process | 0.80 |
| Tissue Stiffness | causes | biomarker | 0.80 |
| Neurogenesis | causes | process | 0.80 |
| Memory Performance | causes | phenotype | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GJA1 | associated_with | gene | 0.95 |
| Amyloid-Beta | contributes_to | protein | 0.95 |
| Tau | contributes_to | protein | 0.95 |
| Bispecific Antibodies | treats | drug | 0.95 |
| Amyloid Beta | causes | protein | 0.95 |
| Tau | causes | protein | 0.95 |
| Blood-Based Biomarkers | biomarker_for | biomarker | 0.95 |
| Rg1 | treats | compound | 0.95 |
| Amyloid Beta | contributes_to | protein | 0.95 |
| Astrocyte | involved_in | cell_type | 0.95 |
| Oligodendrocyte | involved_in | cell_type | 0.95 |
| Gut Microbiota | associated_with | process | 0.95 |
| APP | causes | gene | 0.95 |
| PSEN1 | causes | gene | 0.95 |
| PSEN2 | causes | gene | 0.95 |
| Neurofibrillary Tangles | biomarker_for | biomarker | 0.95 |
| Amyloid Plaque | biomarker_for | biomarker | 0.95 |
| MAPT | biomarker_for | protein | 0.95 |
| APP | biomarker_for | protein | 0.95 |
| HAVCR2 | associated_with | gene | 0.95 |
| MST1 | targets | gene | 0.95 |
| Neuroinflammation | involved_in | process | 0.95 |
| Amyloid-Β | biomarker_for | biomarker | 0.95 |
| Cyclosporine A | modulates | drug | 0.95 |
| SORL1 | risk_factor_for | gene | 0.95 |
| APOE4 | risk_factor_for | gene | 0.95 |
| SYN1 | associated_with | protein | 0.95 |
| Honokiol | treats | compound | 0.95 |
| Stem Cell Therapies | treats | process | 0.95 |
| Atherosclerosis | risk_factor_for | disease | 0.95 |
| Genetic Variation | associated_with | mechanism | 0.95 |
| Amyloid-Beta | associated_with | protein | 0.95 |
| TAU | associated_with | protein | 0.95 |
| YKL-40 | biomarker_for | protein | 0.95 |
| Amyloid Beta Deposition | associated_with | mechanism | 0.95 |
| Tau Tangle Formation | associated_with | mechanism | 0.95 |
| Bd-Tau | biomarker_for | biomarker | 0.95 |
| Amyloid-Β | contributes_to | compound | 0.95 |
| HDAC3 | involved_in | gene | 0.95 |
| MAPT | associated_with | gene | 0.95 |
| Diabetes Mellitus | associated_with | disease | 0.95 |
| Glymphatic System | involved_in | process | 0.95 |
| Parthanatos | involved_in | pathway | 0.95 |
| Brain Aging | risk_factor_for | process | 0.95 |
| SIRT3 | associated_with | gene | 0.95 |
| PPARGC1A | downregulates | gene | 0.95 |
| TDP-43 | biomarker_for | protein | 0.95 |
| Ageing | risk_factor_for | process | 0.95 |
| Amyloid Plaques | biomarker_for | biomarker | 0.95 |
| Tau Pathology | biomarker_for | phenotype | 0.95 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650
neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.527
neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.578
neurodegeneration | 2026-04-14 | 0 hypotheses
neuroinflammation | 2026-04-14 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| External fixation versus reverse shoulder arthroplasty for proximal humerus frac [PMID:41940987] | Vadalà A, Benelli C, Suraci F, Carta B, | Arch Orthop Trauma Surg | 2026 | 0 |
| Gray matter structural and molecular signatures in Alzheimer's disease and late- [PMID:41419068] | Yang S, Wang X, Yan Y, Zhang J, Wei Y et | J Affect Disord | 2026 | 0 |
| Cytomegalic parvalbumin neurons in fetal cases of hemimegalencephaly. [PMID:39973610] | Gelot AB, Draia-Nicolau TO, Mathieu R, S | Epilepsia | 2025 | 0 |
| Brain connectivity and transcriptional changes induced by rTMS in first-episode [PMID:40274783] | Guan M, Xie Y, Wang Z, Miao Y, Li X et a | Transl Psychiatry | 2025 | 0 |
| Single-cell RNA sequencing of adult primate neocortex reveals the regulatory dyn [PMID:40385068] | Zhang C, Xie Z, Wang N | Am J Transl Res | 2025 | 0 |
| Human stem cell-derived GABAergic interneuron development reveals early emergenc [PMID:40651475] | Bershteyn M, Zhou H, Fuentealba L, Chen | Neuron | 2025 | 0 |
| Enhancer AAV toolbox for accessing and perturbing striatal cell types and circui [PMID:40403704] | Hunker AC, Wirthlin ME, Gill G, Johansen | Neuron | 2025 | 0 |
| Forebrain assembloids support the development of fast-spiking human PVALB+ corti [PMID:40695284] | Walsh RM, Crabtree GW, Kalpana K, Jubier | Neuron | 2025 | 0 |
| Anterior cingulate cortex parvalbumin and somatostatin interneurons shape social [PMID:40320404] | Qi C, Sima W, Mao H, Hu E, Ge J et al. | Nat Commun | 2025 | 0 |
| Distinct dendritic integration strategies control dynamics of inhibition in the [PMID:40592329] | Morabito A, Zerlaut Y, Dhanasobhon D, Be | Neuron | 2025 | 0 |
| Targeting SARM1 improves autophagic stress-induced axonal neuropathy. [PMID:37561040] | Kim HR, Lee HJ, Jeon Y, Jang SY, Shin YK | Autophagy | 2024 | 0 |
| Integrated multimodal cell atlas of Alzheimer's disease. [PMID:39402379] | Gabitto MI, Travaglini KJ, Rachleff VM, | Nat Neurosci | 2024 | 0 |
| Identification of early Alzheimer's disease subclass and signature genes based o [PMID:39650656] | Wang W, Lu J, Pan N, Zhang H, Dai J et a | Front Immunol | 2024 | 0 |
| Cortical somatostatin long-range projection neurons and interneurons exhibit div [PMID:38086373] | Fisher J, Verhagen M, Long Z, Moissidis | Neuron | 2024 | 0 |
| Locus Coeruleus-Dorsolateral Septum Projections Modulate Depression-Like Behavio [PMID:38155473] | Zhang Q, Xue Y, Wei K, Wang H, Ma Y et a | Adv Sci (Weinh) | 2024 | 0 |
| Somatostatin and the pathophysiology of Alzheimer's disease. [PMID:38484981] | Almeida VN | Ageing Res Rev | 2024 | 0 |
| Somatostatin interneurons control the timing of developmental desynchronization [PMID:38599213] | Mòdol L, Moissidis M, Selten M, Oozeer F | Neuron | 2024 | 0 |
| De novo gene synthesis by an antiviral reverse transcriptase. [PMID:39116258] | Tang S, Conte V, Zhang DJ, Žedaveinytė R | Science | 2024 | 0 |
| Signature morphoelectric properties of diverse GABAergic interneurons in the hum [PMID:37824669] | Lee BR, Dalley R, Miller JA, Chartrand T | Science | 2023 | 0 |
| Novel App knock-in mouse model shows key features of amyloid pathology and revea [PMID:35690868] | Xia D, Lianoglou S, Sandmann T, Calvert | Mol Neurodegener | 2022 | 0 |